Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet aggregation in hyperlipoproteinemias]

S Calabrese, P G Da Col, C Giansante

    Minerva Medica
    |May 26, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Probing nuclear interactions à la Rutherford: insights on <sup>4</sup>He from α scattering.

    Nature communications·2026
    Same author

    Assessment of Diagnostic Tools to Detect Acute Gas Bubble Disease in Atlantic Salmon (Salmo salar L.).

    Journal of fish diseases·2025
    Same author

    Impact of migration on diabetes burden: audit in the metropolitan area of Bologna, Italy.

    Journal of endocrinological investigation·2023
    Same author

    Hellenic karst waters: geogenic and anthropogenic processes affecting their geochemistry and quality.

    Scientific reports·2023
    Same author

    Airways management in SARS-COV-2 acute respiratory failure: A prospective observational multi-center study.

    Medicina intensiva·2023
    Same author

    Airways management in SARS-COV-2 acute respiratory failure: A prospective observational multi-center study.

    Medicina intensiva·2022

    Platelet aggregation is increased in hyperlipoproteinemia type IIA patients, particularly when induced by epinephrine. Family history of myocardial infarction or diabetes mellitus also impacts platelet aggregation.

    Area of Science:

    • Cardiovascular Science
    • Hematology
    • Metabolic Disorders

    Context:

    • Hyperlipoproteinemia is associated with increased cardiovascular risk.
    • Platelet aggregation plays a key role in thrombosis.
    • Understanding platelet behavior in dyslipidemia is crucial for risk stratification.

    Purpose:

    • To investigate platelet aggregation patterns in various types of hyperlipoproteinemia.
    • To determine if hyperlipoproteinemia influences platelet aggregation.
    • To explore the impact of family history on platelet function in these patients.

    Summary:

    • Platelet aggregation was studied in 42 hyperlipoproteinemic patients across different types (IIA, IIB, IV, V) and 42 controls.
    • A statistically significant increase in platelet aggregation was observed in type IIA hyperlipoproteinemia, specifically when induced by epinephrine.

    Related Experiment Videos

  • No significant difference in platelet aggregation was found between hyperlipoproteinemic smokers and non-smokers.
  • A positive family history of myocardial infarction or diabetes mellitus was found to affect platelet aggregation.

    • Impact:

    • Findings suggest that type IIA hyperlipoproteinemia may predispose individuals to thrombotic events.
    • Epinephrine-induced platelet aggregation could serve as a biomarker for cardiovascular risk in hyperlipoproteinemia.
    • Family history may identify individuals with a higher predisposition to altered platelet function, warranting closer monitoring.